Oncotarget

Corrections:

Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine

PDF  |  How to cite

Oncotarget. 2018; 9:32402-32402. https://doi.org/10.18632/oncotarget.26019

Metrics: PDF 1543 views  |   ?  

Yao-Yu Hsieh1,2,5, Tsui-Chin Huang1,3, Hsiang-Ling Lo1,3, Jyun-Yan Jhan1,3, Shui-Tein Chen1,4 and Pei-Ming Yang1,3

1 PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan
2 Division of Hematology and Oncology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
3 Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
4 Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan
5 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Published: August 17, 2018

This article has been corrected: The author affiliation is given below:

Yao-Yu Hsieh1,2,5

5 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Original article: Oncotarget. 2016; 7:27363-27378. DOI: https://doi.org/10.18632/oncotarget.8455.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26019